Transition to Targeted Therapies Improved the Prognosis and Increased the Utilization of Medical Treatments among Patients with Synchronous Metastatic Renal Cell Cancer

Figure 2

Kaplan–Meier analysis comparing overall survival of patients according to their diagnostic period (2005–2007 vs. 2008–2010).